DG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/0:0) (BioCAD00000021137)

blood feces all tissues

Metabolite Card

Formula: C43H72O5 (668.5379)
SMILES: [H][C@](CO)(COC(=O)CCCCCCC\C=C/C\C=C/CCCCC)OC(=O)CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC

Synonyms [en]

DG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/0:0); DG(40:6); 1-Linoleoyl-2-adrenoyl-sn-glycerol; 1-(9Z,12Z-octadecadienoyl)-2-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycerol; Diacylglycerol(18:2w6/22:4w6); DAG(18:2n6/22:4n6)

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

DG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/0:0). 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000021137). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

DG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/0:0), in particular, consists of one chain of linoleic acid at the C-1 position and one chain of adrenic acid at the C-2 position. The linoleic acid moiety is derived from seed oils, while the adrenic acid moiety is derived from animal fats. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.

Entity Information

DBLinks

Other DBLinks
  • PubChem: 9543879
  • ChEBI: ChEBI:89176
  • HMDB: HMDB0007263
  • LipidMaps: LMGL02010214
  • Metlin: METLIN_4558
  • Coconut NaturalProduct: CNP0084466.2
  • Coconut NaturalProduct: CNP0084497.1
  • Coconut NaturalProduct: CNP0084497.2
  • Coconut NaturalProduct: CNP0084876.2

Class / Ontology

Metabolic Network
ID EC Number Name
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
PathBank:SMP0066836 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0066840 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/24:0)
PathBank:SMP0075592 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0090865 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0024331 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:2(13Z,16Z))
PathBank:SMP0024335 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/18:4(6Z,9Z,12Z,15Z))
PathBank:SMP0024339 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0066839 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0071504 Phosphatidylethanolamine Biosynthesis PE(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0075591 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z))
PathBank:SMP0075595 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/24:1(15Z))
PathBank:SMP0080649 Phosphatidylcholine Biosynthesis PC(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0090864 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0024330 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z))
PathBank:SMP0024334 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/18:3(9Z,12Z,15Z))
PathBank:SMP0024338 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0066838 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z))
PathBank:SMP0033288 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/20:3(8Z,11Z,14Z))
PathBank:SMP0075590 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z))
PathBank:SMP0075594 De Novo Triacylglycerol Biosynthesis TG(18:2(9Z,12Z)/22:4(7Z,10Z,13Z,16Z)/24:0)
View All Pathways